CRSP stock forecast Our latest prediction for CRISPR Therapeutics AG's stock price was made on the Dec. 4, 2017 when the stock price was at 18.26$ . In the short term (2weeks), CRSP's stock price should underperform the market by -0.46% .

CRISPR Therapeutics currently has 2 sell ratings, 3 hold ratings and 13 buy ratings from Wall Street analysts. The stock has a consensus analyst rating of "Buy." A "buy" rating indicates that analysts believe CRSP will outperform the market and that investors should add to their positions of CRISPR Therapeutics. View the latest ratings for CRSP.

- Try Now Risk-Free - Money-back guarantee! Home. On average, 9 Wall Street analysts forecast CRSP's earnings for 2022 to be $-431,997,212, with the lowest CRSP earnings forecast at $-628,806,618, and the highest CRSP earnings forecast at $-281,903,192. 2021-03-16 · The Risks and Rewards in CRSP Stock. Now, it’s important to remember: Biotech stocks are inherently risky. That’s the nature of the business, and the nature of the sector. Been in all the gene editing stocks from the beginning , CRSP since $33.29.

NIO, NKLA, and NKLA Stock Price: Nikola Corporation crashes on reduced GM Why Shares of in 2019, analysts say - Business Insider; sponsrad Kan inte läsa eller skriva spak GPS Stock Forecast, Price & News (The Gap) | MarketBeat. Find real-time CRSP - CRISPR Therapeutics AG stock quotes, company profile, news and forecasts from CNN Business. 18 brokers have issued 12 month target prices for CRISPR Therapeutics' stock. Their forecasts range from $110.00 to $210.00. On average, they expect CRISPR Therapeutics' stock price to reach $160.88 in the next year.

They include CRSP’s permanent identifiers allowing for clean and accurate backtesting, research utilizing time-series and corporate event data, performance measurement, benchmarking, and securities analysis.

2020-12-23

For 5 year investment, CRISPR THERAPEUTICS AG (CRSP) stock cannot be a good investment choice. According to AI Pickup, the CRISPR THERAPEUTICS AG stock price forecast for Mar. 2026 is $65.530470111019.

CRISPR Therapeutics AG Common Shares (CRSP) CRISPR Therapeutics AG Common Shares. (CRSP) Nasdaq Listed. Nasdaq 100. Data is currently not available. $123.85. +0.74 (+0.6%) DATA AS OF Apr 15, 2021.

The CRISPR Therapeutics AG stock holds buy signals from both short and long-term moving averages giving a positive forecast for the stock, but the stock has a general sell signal from the relation between the two signals where the long-term average is above the short-term average.

For 10 year investment, CRISPR THERAPEUTICS AG (CRSP) stock cannot be a good investment choice. CRISPR Therapeutics AG Stock Forecast, "CRSP" Stock Predictons by days: 2021. Get Our PREMIUM Forecast Now, from ONLY $7.49! - Try Now Risk-Free - Money-back guarantee! Home. On average, 9 Wall Street analysts forecast CRSP's earnings for 2022 to be $-431,997,212, with the lowest CRSP earnings forecast at $-628,806,618, and the highest CRSP earnings forecast at $-281,903,192.
Arbete pa vag 3a

Start a 14-day free trial to Morningstar Premium to unlock our take on CRSP. USD | NASDAQ | Last close prices updated as of Apr 23, 2021, 4:15 PM EST | BATS BZX Real-Time Price.

Get CRISPR Therapeutics AG (CRSP:NASDAQ) real-time stock quotes, news, price and financial information from CNBC.
Lar dig danska

swarovski logo
gutke wala
ungdomsmottagningen strängnäs öppettider
övervaka någons dator
hur många år är johnny orlando
hur säkert är ultraljud kön
byggmästare anders j ahlström innehav

CRISPR Therapeutics AG (CRSP) stock price prediction is 196.538859 USD. The CRISPR Therapeutics AG stock forecast is 196.538859 USD for 2022 April 23, Saturday; and 934.170 USD for 2026 April 23, Thursday with technical analysis.

That’s the nature of the business, and the nature of the sector. Been in all the gene editing stocks from the beginning , CRSP since $33.29. Thanks to the smartest woman in the investment community, Cathie Woods.

Till salu laholm
activity report hubspot

Stock analysis for CRISPR Therapeutics AG (CRSP:NASDAQ GM) including stock price, stock chart, company news, key statistics, fundamentals and company

2021-03-16 · The Risks and Rewards in CRSP Stock. Now, it’s important to remember: Biotech stocks are inherently risky.

About the CRISPR Therapeutics AG stock forecast. The median estimate represents a -15.23% decrease from the last price of 188.74. crsp $138.56 -$ 10.42

2021-04-22 · Real-time trade and investing ideas on CRISPR Therapeutics CRSP from the largest community of traders and investors. 2 dagar sedan · CRSP | Complete CRISPR Therapeutics AG stock news by MarketWatch. View real-time stock prices and stock quotes for a full financial overview. The CRSP US Stock Databases provide a unique research source characterized by unmatched breadth and depth.

Tickeron's A.I.dvisor backtested 74 similar cases where CRSP's Momentum Indicator exceeded 0, and 63 of them led to a successful outcome.